Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nitro Alkene Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103588833A reveals a novel tulathromycin synthesis avoiding toxic cyanide and expensive palladium, offering significant cost reduction and high purity for veterinary pharmaceutical manufacturing.
Patent CN103613551A details a novel rare earth-catalyzed route for 1,5-disubstituted-1,2,3-triazoles, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.